Nasdaq notifies HCTI of delisting over warrant dilution concerns

Healthcare Triangle, Inc.

Nasdaq notified HCTI on May 20, 2025, of intent to delist under Rule 5101 due to public interest concerns from warrant reset provisions.
Warrants issued in Feb 27, 2025 private placement (Series A & B) contain reset clauses that can cause substantial shareholder dilution.
Company must present written views to Nasdaq Hearing Panel by May 30, 2025.
Company plans to submit a compliance plan and also apply for OTCQB trading as a backup if delisted.

item 3.01

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.